Banc of America upgraded Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) from a 'neutral' to 'buy' rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE